0001401708-20-000028.txt : 20200218
0001401708-20-000028.hdr.sgml : 20200218
20200218171917
ACCESSION NUMBER: 0001401708-20-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200218
DATE AS OF CHANGE: 20200218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAY R BRADLEY
CENTRAL INDEX KEY: 0001575739
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35980
FILM NUMBER: 20626434
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 2000
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NanoString Technologies Inc
CENTRAL INDEX KEY: 0001401708
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 200094687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-378-6266
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
wf-form4_158206434070072.xml
FORM 4
X0306
4
2020-02-14
0
0001401708
NanoString Technologies Inc
NSTG
0001575739
GRAY R BRADLEY
530 FAIRVIEW AVENUE N
SEATTLE
WA
98109
1
1
0
0
President and CEO
Common Stock
2020-02-14
4
M
0
20000
2.24
A
70050
D
Common Stock
2020-02-14
4
S
0
20000
33.6282
D
50050
D
Stock Option (right to buy)
2.24
2020-02-14
4
M
0
20000
2.24
D
2020-06-29
Common Stock
20000.0
6924
D
The sales reported by Mr. Gray were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2019.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.50 to $33.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The option is subject to an early exercise provision and is immediately exercisable. 25% of the shares subject to the Option vest on the one year anniversary of June 25, 2010 (the "Vesting Commencement Date"), and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the Vesting Commencement Date.
/s/ Shannon Atchison, Attorney in Fact
2020-02-18